Literature DB >> 22248530

Population-based analysis of inpatient vascular procedures and predicting future workload and implications for training.

Jeffrey Jim1, Pamela L Owens, Luis A Sanchez, Brian G Rubin.   

Abstract

OBJECTIVE: The purpose of this study was to analyze the trend in inpatient vascular procedures in the United States over the past decade and predict the future demand for vascular surgeons.
METHODS: The Healthcare Cost and Utilization Project Nationwide Inpatient Sample was queried to determine the weighted national estimates of inpatient vascular procedures performed on adult patients (age ≥ 18) between 1997 and 2008. Using population estimates from the United States Census Bureau, the per capita rates of inpatient procedures were calculated for age-specific groups (18-64 years, 65-84 years, and ≥ 85 years). The change in per capita rates over the past decade along with population forecasts were used to predict future workload.
RESULTS: There was a net increase of 22% from 971,046 inpatient vascular procedures for all adults in 1997 to 1,188,332 in 2008. During the same time period, the adult population increased by 16% from 198 to 230 million. The age-stratified per capita rates of all vascular procedures were +21% for age 18 to 64; -4% for age 65 to 84; and +18% for age ≥ 85. This resulted in a net increase of 5% (490 to 515 procedures per 100,000 capita) in the per capita rate for all adults. Based on the assumption that trends in age-specific rates remain constant, there is a predicted inpatient workload increase (compared to 2008) of 18% by 2015, 34% by 2020, and 72% by 2030. The vascular workload is predicted to more than double by the year 2040.
CONCLUSIONS: Despite a conservative approach of using a population-based analysis of only inpatient procedures, there is a dramatic increase in the predicted vascular workload for the future. The vascular surgery training process will need to adapt to ensure an adequate number of fellowship-trained vascular surgeons is available to provide quality vascular care in the future.
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22248530     DOI: 10.1016/j.jvs.2011.11.061

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

1.  Unimolecular Micelle-Based Hybrid System for Perivascular Drug Delivery Produces Long-Term Efficacy for Neointima Attenuation in Rats.

Authors:  Guojun Chen; Xudong Shi; Bowen Wang; Ruosen Xie; Lian-Wang Guo; Shaoqin Gong; K Craig Kent
Journal:  Biomacromolecules       Date:  2017-06-14       Impact factor: 6.988

2.  A rapamycin-releasing perivascular polymeric sheath produces highly effective inhibition of intimal hyperplasia.

Authors:  Xiaohua Yu; Toshio Takayama; Shakti A Goel; Xudong Shi; Yifan Zhou; K Craig Kent; William L Murphy; Lian-Wang Guo
Journal:  J Control Release       Date:  2014-05-20       Impact factor: 9.776

3.  Endovascular training of vascular surgeons in the USA.

Authors:  Roland Assi; Alan Dardik
Journal:  Ann Vasc Dis       Date:  2012-11-15

4.  Mortality and Cost of Acute and Chronic Kidney Disease after Vascular Surgery.

Authors:  Matthew Huber; Tezcan Ozrazgat-Baslanti; Paul Thottakkara; Philip A Efron; Robert Feezor; Charles Hobson; Azra Bihorac
Journal:  Ann Vasc Surg       Date:  2015-07-14       Impact factor: 1.466

5.  Cardiovascular-Specific Mortality and Kidney Disease in Patients Undergoing Vascular Surgery.

Authors:  Matthew Huber; Tezcan Ozrazgat-Baslanti; Paul Thottakkara; Salvatore Scali; Azra Bihorac; Charles Hobson
Journal:  JAMA Surg       Date:  2016-05-01       Impact factor: 14.766

Review 6.  Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery.

Authors:  Mirnal A Chaudhary; Lian-Wang Guo; Xudong Shi; Guojun Chen; Shaoqin Gong; Bo Liu; K Craig Kent
Journal:  J Control Release       Date:  2016-05-12       Impact factor: 9.776

7.  Restenosis Inhibition and Re-differentiation of TGFβ/Smad3-activated Smooth Muscle Cells by Resveratrol.

Authors:  Yichen Zhu; Toshio Takayama; Bowen Wang; Alycia Kent; Mengxue Zhang; Bernard Y K Binder; Go Urabe; Yatao Shi; Daniel DiRenzo; Shakti A Goel; Yifan Zhou; Christopher Little; Drew A Roenneburg; Xu Dong Shi; Lingjun Li; William L Murphy; K Craig Kent; Jianjuan Ke; Lian-Wang Guo
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

8.  Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease.

Authors:  Line Ea Hemstra; Anders Schlosser; Jes Sanddal Lindholt; Grith L Sorensen
Journal:  J Transl Med       Date:  2018-06-08       Impact factor: 5.531

Review 9.  Preoperative evaluation and perioperative management of patients undergoing major vascular surgery.

Authors:  Christopher Lee; Jesse A Columbo; David H Stone; Mark A Creager; Stanislav Henkin
Journal:  Vasc Med       Date:  2022-10       Impact factor: 4.739

10.  Periadventitial application of rapamycin-loaded nanoparticles produces sustained inhibition of vascular restenosis.

Authors:  Xudong Shi; Guojun Chen; Lian-Wang Guo; Yi Si; Men Zhu; Srikanth Pilla; Bo Liu; Shaoqin Gong; K Craig Kent
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.